Dong Song Wei
Corporate Secretary at SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.
Net worth: 29 397 $ as of 30/06/2024
Dong Song Wei active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Corporate Secretary | 09/01/2012 | - |
| Corporate Officer/Principal | 18/08/2011 | 09/01/2012 | |
Sinopharm YiXin Pharmaceutical Co., Ltd.
 Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Director/Board Member | - | - |
Career history of Dong Song Wei
Statistics
International
| China | 3 |
Operational
| Corporate Officer/Principal | 1 |
| Corporate Secretary | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Sinopharm YiXin Pharmaceutical Co., Ltd.
Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Health Technology |
- Stock Market
- Insiders
- Dong Song Wei
- Experience
